SCHEMBL2330372

SCHEMBL2330372

CCCCCC(=O)c1cccc(C(=O)N[C@@H](CS(=O)(=O)O)C(=O)O)c1OC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.38
CA2 P00918 1/20 0.36
CTSS P25774 1/20 0.36
SIRT2 Q8IXJ6 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
TAS1R3 Q7RTX0 1/20 0.36
TAS1R1 Q7RTX1 1/20 0.36
APEX1 P27695 1/20 0.35
ALDH1A1 P00352 1/20 0.35
PYGL P06737 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
MMP12 P39900 1/20 0.35
MMP14 P50281 1/20 0.35
ITGB1 P05556 1/20 0.35
ITGA4 P13612 1/20 0.35
PTPN2 P17706 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2330407 0.93 USP2 (0.39) USP2CA2CTSSFNTAFNTB
SCHEMBL2324220 0.84 USP2 (0.42) USP2CA2CTSSAPEX1ALDH1A1
SCHEMBL2333701 0.83 TAS1R3 (0.40) USP2CA2CTSSFNTAFNTB
SCHEMBL2324780 0.81 USP2 (0.43) USP2CA2CTSSTAS1R3TAS1R1
SCHEMBL2329702 0.80 TAS1R3 (0.40) USP2CA2CTSSFNTAFNTB
SCHEMBL2331119 0.79 HPGD (0.39) CA2FNTAFNTBALDH1A1PYGL
SCHEMBL2331128 0.79 HPGD (0.39) CA2FNTAFNTBALDH1A1PYGL
SCHEMBL2326565 0.76 CA12 (0.41) CA2PYGLMMP2MMP9MMP8
SCHEMBL2326571 0.76 CA12 (0.41) CA2PYGLMMP2MMP9MMP8
SCHEMBL2330498 0.75 HDAC1 (0.58) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2356979-B1 ANTI-WRINKLE AGENTS POLA CHEM IND INC (JP) 2017-10-25 EP disclosed
EP-3173063-A1 ANTI-WRINKLE AGENTS Pola Chemical Industries Inc. (JP) 2017-05-31 EP disclosed
US-8835498-B2 Anti-wrinkle agents POLA CHEMICAL INDUSTRIES INC. (JP) 2014-09-16 US disclosed
US-20110245343-A1 ANTI-WRINKLE AGENTS POLA CHEMICAL INDUSTRIES INC. (JP) 2011-10-06 US disclosed
EP-2356979-A1 ANTI-WRINKLE AGENTS Pola Chemical Industries Inc. (JP) 2011-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245343-A1 ANTI-WRINKLE AGENTS GLA, H1-4, H1-3 USP2 2398/4885CA2 2926/4885CTSS 2035/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.